Celularity Inc (CELUW) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
170 PARK AVE FLORHAM PARK, NJ 07932 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 227 | 13,966 | 37,240 | 315 | 917 | |||
| Cash and cash equivalent | 227 | 13,966 | 37,240 | 315 | 917 | |||
| Receivables | (5,837) | (1,789) | (283) | |||||
| Inventory, net of allowances, customer advances and progress billings | 5,753 | 5,308 | 9,549 | |||||
| Inventory | 5,753 | 5,308 | 9,549 | |||||
| Prepaid expense | 1,007 | 1,426 | 7,076 | 45 | 92 | |||
| Other current assets | 2 | |||||||
| Other undisclosed current assets | 18,643 | 14,591 | 5,516 | |||||
| Total current assets: | 19,793 | 33,502 | 59,100 | 359 | 1,009 | |||
| Noncurrent Assets | ||||||||
| Inventory, Noncurrent | 16,657 | 22,949 | 2,721 | |||||
| Operating lease, right-of-use asset | 10,990 | 13,060 | ||||||
| Property, plant and equipment | 67,828 | 75,655 | 90,625 | |||||
| Intangible assets, net (including goodwill) | 18,348 | 240,688 | 246,491 | |||||
| Goodwill | 7,347 | 119,694 | 123,304 | |||||
| Intangible assets, net (excluding goodwill) | 11,001 | 120,994 | 123,187 | |||||
| Asset, held-in-trust | 291,797 | 290,595 | ||||||
| Restricted cash and investments | 9,936 | 14,836 | 14,836 | |||||
| Other noncurrent assets | 337 | 376 | 355 | |||||
| Other undisclosed noncurrent assets | 2 | |||||||
| Total noncurrent assets: | 124,096 | 367,564 | 355,028 | 291,797 | 290,596 | |||
| TOTAL ASSETS: | 143,889 | 401,066 | 414,128 | 292,156 | 291,605 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 21,724 | 22,212 | 20,978 | 3,410 | 210 | |||
| Taxes payable | ✕ | ✕ | ✕ | 19 | ||||
| Accounts payable | 14,144 | 5,810 | 9,317 | |||||
| Accrued liabilities | 7,580 | 16,402 | 11,661 | |||||
| Other undisclosed accounts payable and accrued liabilities | 3,410 | 191 | ||||||
| Deferred revenue | 2,834 | 2,273 | 2,196 | |||||
| Debt | 17,223 | 37,603 | ||||||
| Other undisclosed current liabilities | 25,517 | 3,051 | 19 | |||||
| Total current liabilities: | 67,298 | 62,088 | 26,225 | 3,410 | 229 | |||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 29,666 | 30,534 | 2,216 | 1 | ||||
| Deferred revenue | 3,186 | 2,219 | 1,871 | |||||
| Deferred income tax liabilities | 9 | 9 | 10 | 1 | ||||
| Other liabilities | 294 | 321 | 335 | |||||
| Operating lease, liability | 26,177 | 27,985 | ||||||
| Other undisclosed noncurrent liabilities | 5,965 | 109,543 | 286,269 | 74,613 | 10,813 | |||
| Total noncurrent liabilities: | 35,631 | 140,077 | 288,485 | 74,613 | 10,813 | |||
| Total liabilities: | 102,929 | 202,165 | 314,710 | 78,023 | 11,042 | |||
| Temporary equity, including noncontrolling interest | 209,133 | 275,564 | ||||||
| Equity | ||||||||
| Equity, attributable to parent, including: | 40,960 | 198,901 | 99,418 | 5,000 | 5,000 | |||
| Common stock | 19 | 15 | 12 | 1 | ||||
| Additional paid in capital | 882,732 | 844,373 | 763,087 | 48,381 | 2,487 | |||
| Accumulated other comprehensive income (loss) | 9 | |||||||
| Retained earnings (accumulated deficit) | (841,791) | (645,496) | (663,681) | (43,383) | 2,512 | |||
| Other undisclosed equity, attributable to parent | 1 | 1 | ||||||
| Total equity: | 40,960 | 198,901 | 99,418 | 5,000 | 5,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 143,889 | 401,066 | 414,128 | 292,156 | 291,605 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 22,771 | 17,975 | 21,335 | ||||
| Cost of revenue | (87,478) | (144,198) | (159,693) | ||||
| Cost of product and service sold | (87,478) | (144,198) | (159,693) | ||||
| Other undisclosed gross profit | 71,462 | 124,533 | 150,040 | ||||
| Gross profit: | 6,755 | (1,690) | 11,682 | ||||
| Operating expenses | (304,614) | (150,187) | (161,886) | (4,220) | (564) | ||
| Other undisclosed operating income | 105,572 | 126,277 | 41,145 | ||||
| Operating loss: | (192,287) | (25,600) | (109,059) | (4,220) | (564) | ||
| Nonoperating income (expense) | (3,998) | 39,805 | 8,961 | (44,849) | 3,746 | ||
| Investment income, nonoperating | 1,779 | 3,753 | |||||
| Other nonoperating income (expense) | (2,695) | 365 | (2,839) | ||||
| Interest and debt expense | (1,367) | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (196,285) | 14,205 | (100,098) | (50,436) | 3,181 | ||
| Other undisclosed income from continuing operations before income taxes | 1,367 | ||||||
| Income (loss) from continuing operations before income taxes: | (196,285) | 14,205 | (100,098) | (49,069) | 3,181 | ||
| Income tax expense | (10) | (13) | (20) | (192) | (668) | ||
| Other undisclosed income (loss) from continuing operations | 48,980 | ||||||
| Income (loss) from continuing operations: | (196,295) | 14,192 | (100,118) | (281) | 2,513 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (100,118) | (281) | 2,513 | |
| Net income (loss): | (196,295) | 14,192 | (100,118) | (281) | 2,513 | ||
| Net income attributable to noncontrolling interest | 50,256 | ||||||
| Other undisclosed net loss attributable to parent | (99,236) | ||||||
| Net income (loss) attributable to parent: | (196,295) | 14,192 | (100,118) | (49,260) | 2,513 | ||
| Preferred stock dividends and other adjustments | (2,731) | ||||||
| Net income (loss) available to common stockholders, diluted: | (196,295) | 14,192 | (100,118) | (49,260) | (218) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (196,295) | 14,192 | (100,118) | (281) | 2,513 | ||
| Comprehensive income (loss): | (196,295) | 14,192 | (100,118) | (281) | 2,513 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 146 | 9 | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | (196,149) | 14,201 | (100,118) | (281) | 2,513 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.